Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading lower after the market close on Tuesday following the company’s quarterly results. Here’s a rundown of the report.
What Happened: Recursion reported fourth-quarter revenue of $10.89 million, which missed the consensus estimate of $20.35 million. The clinical stage biotech company reported a quarterly loss of 42 cents per share, which beat estimates for a loss of 44 cents per share.
Recursion said it ended the quarter with $391.6 million in cash and cash equivalents.
“As we have watched the …